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Case Presentation* 
A 5 1 -year-old white man suffered an infe- 
rior wall myocardial infarction in 198 1. He was 
treated at another hospital and subsequently 
underwent coronary artery bypass grafting 
~ (CABG) to four vessels. After this surgery he 
0 continued to have infrequent chest pain con- 
= 
2 trolled with sublingual nitroglycerin. 
6 
g 
In July 1986, the patient developed severe 
4 
substernal chest pain unrelieved by nitroglycerin. 
3 
He was seen in an emergency room at another 
2 
hospital and was transferred to this hospital for 
G emergent intervention. One year prior to this a 
5 
admission the patient had undergone repeat car- 
I 
disc catheterization which reportedly revealed 
M 
& 
that one of his grafts had become occluded. An 
8 electrocardiogram done in the referring emer- r= m gency room revealed an acute inferior wall myo- 
Z 
P cardial infarction. Upon admission to this hospi- 
e a tal he underwent repeat cardiac catheterization 
P 
d 
which revealed complete occlusion of the graft to 
his right coronary artery. Successful percuta- 
neous transluminal graft angioplasty was per- 
formed and 100,000 units of intracoronary strep- 
tokinase were given. His hospital course was 
complicated by dysrhythmias and congestive 
heart failure, each of which was successfully 
treated. He was discharged on captopril, diltia- 
zem, isosorbide dinitrate, and a metaproterenol 
inhaler. 
The patient was readmitted in January 
1987, for a repeat heart catheterization and 
coronary angiography. This revealed stenosis of 
the distal right coronary artery graft, occlusion 
of the left anterior descending and circumflex 
grafts, a left ventricular end-diastolic pressure of 
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29 mmHg, and an ejection fraction of approxi- 
mately 40%. He was referred for repeat CABG. 
The patient was readmitted for a second 
CABG 1 week later. In addition to his docu- 
mented coronary artery disease, he carried the 
diagnoses of chronic obstructive pulmonary dis- 
ease and hypothyroidism. The patient was kept 
NPO after midnight and given lorazepam, 3 mg, 
and morphine sulfate, 12 mg, intramuscularly 
(IM), at 6:00 AM. He was brought to the operat- 
ing room, where two 1Cgauge peripheral intra- 
venous catheters, a left radial arterial catheter, 
and an Oximetric pulmonary artery catheter 
were inserted. During this period he was given 6 
mg of midazolam intravenously. Anesthetic 
induction and endotracheal intubation were 
accomplished without incident using fentanyl, 50 
pug/kg, with pancuronium and metubine used for 
muscle relaxation. Arterial blood gases following 
induction on an FIOz of 1.0 revealed: PaO, 290 
mmHg, PaCO, 33 mmHg, and pH 7.40. Peak 
inspiratory pressure was 30 cmH,O, pulmonary 
artery pressures were 25/9 mmHg, cardiac out- 
put 6.2 L/min, pulse rate was 75 beats/min, and 
systemic blood pressure was 1 lo/70 mmHg. 
The CABG procedure was uneventful until 
massive bleeding occurred during the repeat ster- 
notomy. The patient was immediately heparin- 
ized and an activated coagulation time was mea- 
sured at 600 seconds. Femoral vein-femoral 
artery partial bypass was rapidly instituted while 
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multiple transfusions were given. Once partial 
bypass was instituted, the cardiopulmonary 
bypass (CPB) pump was used as the vehicle for 
further transfusion. A total of 3 1 units of packed 
red blood cells was administered during the 
procedure. A total of six hours of total and 
partial bypass was required for repair of a tear in 
the right ventricle and completion of the CABG. 
During all but 90 minutes of this time the patient 
was normothermic. Difficulty was encountered 
during the initial attempts to terminate CPB. An 
intra-aortic balloon assist device was inserted 
and separation from CPB was achieved, 
although systolic blood pressure never exceeded 
90 mmHg. Multiple cardiac outputs ranged from 
2 to 4 L/min. Arterial blood gases on an F,02 of 
1.0 following separation from CPB revealed a 
PaO, of 41 mmHg, PaCO, 42 mmHg, and pH 
7.21. Additional therapy included PEEP at 10 
cmH,O and infusions of dopamine at 5 hg/ 
kg/min and norepinephrine/phentolamine (2:4) 
at 20 drops/min. The position of the endotra- 
cheal tube was checked and the tube suctioned 
free of a small amount of secretions. Peak inspi- 
ratory pressures were 40 to 45 cmH,O after 
separation from CPB with a tidal volume of 1200 
mL. Arterial blood gases following the institu- 
tion of the above therapeutic measures revealed: 
PaO, 64 mmHg, PaCO, 34 mmHg, pH 7.36 and 
a base excess -8.2 mEq/L. The patient was 
transferred to the thoracic intensive care unit 
(ICU) where the norepinephrine/phentolamine 
infusion was discontinued and an epinephrine 
infusion was begun. His course continued inexor- 
ably downhill and he died approximately 12 
hours postoperatively. He maintained PaO,s of 
75 to 85 mmHg and PaCo,s of 44 to 50 mmHg on 
an F,02 of 1.0 with 10 cmH,O PEEP in the 
ICU. 
DISCUSSION 
Diagnosis and Treatment of Difluse 
Alveolar Damage? 
There is ample evidence that this patient 
developed the adult respiratory distress syn- 
drome (ARDS). The patient had relatively nor- 
mal cardiac filling pressures and severe hypox- 
emia. An important question is whether the 
tJeffrey V. Kyff, DO 
hypoxemia was secondary to an inadequate car- 
diac output. Cardiac output is one of the major 
determinants of oxygenation. With cardiac out- 
puts of 2 to 4 L/min and a cardiac index of 
approximately 2 L/min/m*, this may have con- 
tributed to the hypoxemia. The base excess 
remained approximately -8.2 mEq/L despite the 
intra-aortic balloon pump and inotropic support 
following surgery. The acidosis may have been 
contributed to by blood products, which the 
patient had in abundance. The prime reason for 
the lactic acidosis in this patient, however, was 
inadequate perfusion postoperatively. 
The term “diffuse alveolar damage” 
(DAD) is being used more and more in the 
literature. Fetal hyaline membrane disease and 
ARDS are related in many respects. In the fetal 
form of this condition there is usually uniform 
atelectasis which may be secondary to lack of 
parenchymal development or lack of surfactant. 
In the adult form of DAD patchy atelectasis as 
well as areas of microatelectasis surrounded by 
essentially normal alveoli are seen. Both pro- 
cesses involve formation of a hyaline membrane. 
There are two phases in the adult syndrome. The 
initial exudative phase lasts one to six days and 
involves necrosis of the alveolar type-one cells 
without damage to the basement membrane. 
This leads to increased permeability and pro- 
teinacious exudates. These cause the formation 
of the hyaline membrane and, along with accu- 
mulation of cellular debris, result in atelectasis. 
The changes result in almost total loss of the 
type-one alveolar cells. The second, or reparative, 
phase usually lasts about 2 weeks and may result 
in proliferation of type-two cells as well as fibro- 
sis with honeycombing and chronic interstitial 
pneumonia, or, more commonly, nearly total 
resolution if the patient survives. 
There are many etiologies of ARDS or 
DAD (Table 1). This patient was in shock post- 
operatively. The low-flow state, multiple transfu- 
sions, and CPB are ample etiologic factors in the 
development of DAD. When an extensive list of 
etiologies exists for a disease, it usually means 
that it is not well understood. This seems true in 
terms of burn patients with inhalation injuries, as 
only a minority develop a clear syndrome of 
DAD. Some data from the MGM Grand Hotel 
fire are of interest. There were 600 patients 
evaluated for smoke inhalation. Of those, 318 
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Table 1. ARDS-Associated Etiologies 
Shock Pancreatitis 
Trauma Multiple/massive transfusions 
Fat embolism DIC 
CNS pathology Direct pulmonary damage (inhalation) 
Burns Drug overdose/reaction 
Aspiration Leukemia 
Asphyxiation Cardiopulmonary bypass 
Pulmonary infection Poisoning 
Sepsis Radiation 
Reexpansion of Chemotherapy 
collapsed lung DKA 
Liver failure 
Hypotension 
were admitted with inhalation injuries, but not 
one patient developed DAD.’ It was expected 
that this group with direct pulmonary damage 
would develop DAD. 
To understand DAD and the various mech- 
anisms of pulmonary edema, it is necessary to 
understand the Starling equation: 
Net filtration = Kf [(Pmv - Ppmv) - Sigma 
(mv - pmv)l 
Kf = capillary filtration coefficient 
Pmv = microvascular hydrostatic pressure 
Ppmv = perimicrovascular hydrostatic pressure 
Sigma - protein osmotic reflection coefficient 
mv = plasma oncotic pressure 
pmv = perivascular oncotic pressure 
The Starling equation describes fluid dynamics 
along a capillary bed. The protein osmotic reflec- 
tion coefficient governs what happens with DAD. 
This coefficient expresses the relative permeabil- 
ity of the membrane to protein. As this number 
approaches zero, permeability increases. In 
patients for whom this figure approaches one, 
membranes are impermeable to protein. Further 
consideration of the plasma and perivascular 
oncotic pressures suggests that there are two 
types of pulmonary edema. The first would be 
secondary to increased hydrostatic pressure, ie, 
increased cardiac filling pressures. This, ex- 
pressed as increased pulmonary capillary wedge 
pressure (PCWP), is generally cardiogenic in 
nature, delayed in onset, and characterized by 
low protein content in the edema fluid. The 
second type is due to changes in capillary perme- 
ability and is usually rapid in onset with essen- 
tially normal wedge pressures and a high protein 
content in the edema fluid. Pink frothy sputum is 
not common in DAD, although it is occasionally 
seen. 
The pathophysiology of DAD and the 
mechanisms opposing its development are multi- 
faceted. Usually the hydrostatic pressure 
increases the filtration across capillaries leading 
to a decrease in the interstitial oncotic pressure 
secondary to the dilution of protein in the inter- 
stitial space. This leads to an increase in the 
gradient between the plasma oncotic pressure 
and the perivascular oncotic pressure. Increasing 
lymph flow then works as a protective feature as 
long as the osmotic reflection coefficient (sigma) 
remains one and the barrier remains intact. 
Lymph flow can pick up any additional fluid by 
increasing to a phenomenal rate. This is the 
primary compensatory mechanism limiting pul- 
monary edema. Once the osmotic reflection coef- 
ficient approximates zero there is essentially no 
barrier between the intravascular and interstitial 
spaces. The lymphatics become overwhelmed 
and interstitial edema develops. Hydrostatic 
pressure then becomes much less important 
because there is essentially no barrier to fluid 
flow. Whether the wedge pressure is 3 mmHg or 
10 mmHg is not terribly important. Probably the 
PCWP should not be markedly elevated, but 
there is apparently little benefit to lowering the 
PCWP to zero. Certainly there are hemody- 
namic reasons to maintain a higher filling pres- 
sure. 
Changes in extravascular lung water in 
patients with DAD have been studied.2 Whether 
the fluid utilized was lactated Ringers, saline, 
albumin, or hetastarch does not seem to make a 
great deal of difference in terms of the extravas- 
cular lung watere2 Additionally, Shoemaker et al 
described varied hemodynamic and oxygen 
transport values in response to fluid therapy in 
the setting of DAD.3 
Signs and symptoms of DAD include 
hypoxemia usually unresponsive to peak airway 
pressure, decreased pulmonary static com- 
pliance, and decreased functional residual capac- 
ity. The ARDS seen with high altitude pulmo- 
nary edema is an exception, being responsive to 
the administration of oxygen. Generally, patients 
with DAD will be tachypneic with elevated pul- 
monary hydrostatic pressures, normal-to-low 
PCWP, and pulmonary edema, with or without 
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x-ray evidence.* There is some debate as to 
whether or not x-ray findings are essential to the 
diagnosis of DAD. One of the key signs seen is a 
decrease in pulmonary compliance (defined as 
the change in volume divided by the change in 
airway pressure) usually to less than 50. 
Mortality runs 50% to 60% in patients with 
mild degrees of DAD. When death occurs it 
usually occurs within 2 weeks of onset, most 
often due to the underlying disease process, not 
hypoxemia or inability to ventilate the patient.4 
Gram negative sepsis carries a mortality of 85% 
when it is associated with DAD. The manage- 
ment of DAD patients is directed toward the 
etiology. Hemodynamic monitoring must be used 
aggressively. Supportive care includes mechani- 
cal ventilation (with PEEP), nutritional support, 
and hemodynamic manipulation. Once the 
underlying cause is corrected, it is primarily a 
matter of supporting the patient through the 
exudative phase to the resolution phase. Deciding 
whether or not any given cardiac output is ade- 
quate is most helpful and can be accomplished 
effectively by recording all of the measured 
hemodynamic variables and calculating a num- 
ber of derived values, including the cardiac 
index, stroke index, vascular resistances, and left 
and right ventricular stroke work indices. This 
patient’s cardiac output was 2 to 4 L/min and 
that probably was not adequate in light of the 
arterial and mixed venous gases, the arterial and 
mixed venous O2 content, the A-VD02, and the 
oxygen extraction. A decision about whether or 
not a given cardiac output is adequate is possible 
and therapy may be adjusted accordingly. Other 
important values are the alveolar 02, A-a gra- 
dient, a-ADO,, pulmonary shunt, oxygen con- 
sumption, and pulmonary compliance. 
Ventilation with PEEP is important in the 
supportive care. The “best PEEP curve” can be 
used in the management of these patients. Gen- 
erally patients are intubated and mechanically 
ventilated with added PEEP. The PEEP 
increases the functional residual capacity and 
decreases the pulmonary shunt by converting 
areas of atelectasis and complete shunt to areas 
of alveolar ventilation and partial shunt. A 
patient’s progress can be followed by looking at 
the pulmonary compliance, shunt, and PaO,. 
Nelson et al titrated PEEP in non-ARDS 
patients with early, moderate arterial hypox- 
emia.5 They compared titrating PEEP by plot- 
ting the PEEP curve looking for a shunt of less 
than 20% to simply titrating PEEP to a given 
arterial oxygen saturation and a given Pa02. No 
difference was noted in the two methods. In 
attempting to wean patients off PEEP they found 
it to be more economical to simply titrate to a 
given arterial saturation rather than to maintain 
the shunt at less than 20%. Whether this applies 
to ARDS patients or not needs to be confirmed. 
The arterial-alveolar ratio is the ratio 
between the arterial O2 and alveolar O2 tensions 
with a normal value expressed as 0.8. The advan- 
tages of this value are that it allows comparison 
of different patients on different FrO,s and venti- 
lator settings, as well as allowing comparison of 
the same patient on different days on different 
levels of Fro2 and PEEP. Following the a-ADO, 
in conjunction with the clinical picture and 
hemodynamic variables can be helpful in the 
management of this type of patient. Pervis et al 
used this ratio, and found the best clinical corre- 
lation when a patient had a ratio of 0.55 or less, 
defined as moderate-to-severe respiratory fail- 
ure.6 
Compliance is a parameter followed in the 
operating room or ICU which is easy to calcu- 
late: the tidal volume divided by the peak inspira- 
tory pressure minus the PEEP equals the effec- 
tive static compliance. Compliance decreases 
very early when patients begin to accumulate 
extravascular lung water or pulmonary edema. 
The continuous measurement of SV02 may 
be very helpful, but is very expensive. Oximetric 
pulmonary arterial catheters cost $175.00 in 
comparison to a plain pulmonary arterial cathe- 
ter costing $45.00. More and more studies are 
reporting the advantages of following SV02 as a 
method of monitoring oxygenation. This is prob- 
lematic, however, as many factors affect SV02, 
including the cardiac output, arterial saturation, 
hemoglobin, and metabolic rate. Oxygen con- 
sumption is not a constant number. A patient 
does not stay at a given oxygen consumption 
throughout a 24-hour period in a critical care 
unit or operating room. Oxygen consumption 
tends to be extremely variable and nearly impos- 
sible to predict. If SV02 is monitored in these 
patients this variability must be kept in mind and 
the SV02 value should not be used alone to 
diagnose or treat patients. 
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COMMENTARY 
Basic Pathologic Processes in Difuse 
Alveolar DamageS 
There are multiple etiologies and clinical 
settings in which ARDS may occur.7*8 Two of the 
most important targets of toxic insult to the lung 
are pulmonary capillary endothelial cells and 
type 1 alveolar epithelial cells. Depending upon 
the nature of the toxic insult, injury of one cell 
type may be of greater importance in the patho- 
genesis of the disease process. Pulmonary endo- 
thelial cell injury may lead to a breakdown in the 
intravascular-interstitial barrier resulting in 
increased vascular permeability and lung lymph 
flow. Injury to the alveolar type 1 epithelial cell 
results in a breakdown of the intra-alveolar and 
interstitial barriers with resultant alveolar ede- 
ma. Depending upon the extent of injury to either 
of these cells, a predominance of interstitial 
edema or a mixture of interstitial and intra- 
alveolar edema is seen. In this patient, a combi- 
nation of injury to both cell types probably 
existed. Once this pathologic process is initiated 
it may evolve over several days with the develop- 
ment of the histologic hallmark of diffuse alveo- 
lar damage: the presence of hyaline membranes 
along alveolar walls. These membranes consist 
primarily of cellular debris mixed with various 
amounts of fibrin. This injury frequently will 
progress over a l-to-2 week period with the onset 
of a chronic interstitial inflammatory response, 
progressive interstitial fibrosis, and varying 
degrees of intra-alveolar fibrosis. This is the 
framework of the pathologic progression of 
ARDS as it applies to this case. 
Many experimental models have been 
developed to investigate the pathogenic mecha- 
nisms that are functioning in this disease process. 
As expected in a disease process with multiple 
etiologies, there are multiple pathogenic mecha- 
nisms. One approach that has been taken is based 
on what has been referred to as the complement 
or complement-neutrophil hypothesis.‘-” This 
hypothesis was proposed initially by Craddock et 
al to explain respiratory insufficiency associated 
with hemodialysis.’ In these patients, significant 
complement activation was observed upon expo- 
sure of plasma to dialysis membranes and 
$Joseph C. Fantone, III, MD 
increased levels of circulating anaphylatoxins. In 
particular, the anaphylatoxin C5a, a low molecu- 
lar weight polypeptide, is an important activator 
of circulating polymorphonuclear leukocytes 
(PMNs) and is the primary chemoattractant 
derived from plasma. The generation of C5a 
leads to PMN activation which is manifest as 
increased adherence to endothelial cells, cell 
aggregation, and the release of a variety of toxic 
agents, including reactive oxygen species, lysoso- 
ma1 enzymes, and several biologically-active 
lipid mediators. These phlogistic compounds 
have potentially potent effects both on endothe- 
lial cells and vascular smooth muscle cells. The 
two primary lipid mediators from PMNs are 
leukotriene B4 (LTBJ, derived from arachidonic 
acid metabolism, and platelet activating factor 
(PAF). In ARDS, the early onset of interstitial 
edema is frequently associated with the presence 
of leukocyte aggregates in pulmonary capillaries. 
Similar pathogenic mechanisms have been pro- 
posed to explain CPB-induced lung injury (Fig 
1). 
Several experimental models of ARDS 
have been developed over the years. These 
include models in rabbits, rats, dogs, and sheep.” 
In each case, the models focus on defining the 
effects of systemic activation of complement on 
pulmonary function. Within a few minutes fol- 
lowing systemic activation of the complement 
system the alveolar capillaries appear dilated and 
contain aggregates of PMNs mixed with plate- 
lets and red blood cells. This is frequently asso- 
ciated with injury to endothelial cells and expo- 
sure of denuded vascular basement membrane. 
In addition, there is interstitial edema indicative 
of breakdown in the intravascular-interstitial 
barrier. Depending on the experimental model 
and extent of injury, the breakdown of vascular 
basement membrane and aggregates of fibrin 
indicative of activation of the coagulation system 
are observed. This is the primary morphologic 
correlation developed in experimental model sys- 
tems to explain the early phases of lung injury in 
ARDS. 
A variety of therapeutic interventions in 
addition to the modulation of PMN function 
have been developed recently. These include the 
systemic administration of anti-oxidants in an 
attempt to remove the reactive oxygen species 
that may be generated by activated leuko- 
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cytes.‘2’13 Depending on the experimental model, 
varying success in inhibiting lung injury has been 
observed with the administration of these anti- 
oxidants. It is important to note that although a 
number of models have been proposed and evalu- 
ated for ARDS, none of them is fully satisfacto- 
ry. None of the experimental models progresses 
with significant hyaline membrane formation 
and fibrosis as is frequently observed in patients. 
This may reflect the complexity of the pathologic 
process and the multiple factors that are func- 
tioning. In addition, there are at least four 
reports in the literature describing the develop- 
ment of ARDS in patients who were deficient in 
circulating PMNs and who nevertheless devel- 
oped ARDS. These observations support the 
contention that ARDS is a multifactorial disease 
process. In the future, it will be important to 
examine the impact of a variety of mediators 
which may be generated in both the vascular and 
extravascular compartment of the lung as the 
result of toxic insult to circulating monocytes, as 
well as endothelial cells, alveolar epithelial cells, 
and pulmonary alveolar macrophages. Studies 
focused on defining the role of the monocyte as a 
potentially important cellular mediator of ARDS 
have increased. This is based on the multifunc- 
tional properties of this cell including its ability 
to secrete interleukin- 1, tumor necrosis factor, 
and a variety of other inflammatory mediators 
that modulate the functions of multiple cell types 
both in the vascular compartment and interstitial 
tissues. In addition, significant attention is cur- 
rently focused on the endothelial cell as a 
dynamic partner in the inflammatory response 
rather than a passive bystander. This is based on 
recent studies that have shown that inflamma- 
tory mediators such as interleukin- 1 can directly 
activate these cells to express specific receptors 
on their surface and alter their biologic func- 
tions, including prostacyclin production. Thus, it 
Fig 1. Pathogenic mechanisms of cardiopul- 
monary bypass-induced lung injury. 
appears that complex interactions are potentially 
occurring between circulating inflammatory 
cells and vascular and parenchymal cells during 
the evolution of ARDS. It is hoped that further 
understanding of the complex interactions 
between inflammatory cells and mediators with 
vascular and pulmonary parenchymal cells may 
provide insight into the pathologic mechanisms 
functioning in ARDS, and provide the basis for 
the development of more effective therapeutic 
intervention. 
In certain experimental models pretreat- 
ment with various substances has shown promise. 
Pretreatment with corticosteroids has provided a 
protective effect in some models. In clinical 
studies, however, responses to steroid therapy in 
ARDS patients are quite variable and of ques- 
tionable efficacy. 
In experimental studies, Morganroth has 
shown a protective effect of lodoxamide, a xan- 
thine oxidase inhibitor, after ischemic reperfu- 
sion injury in isolated perfused rat lungs.14 A 
similar protective effect of allopurinol and oxy- 
purinol has been observed in ischemic reperfu- 
sion injury of other tissues including heart and 
intestine.15 The use of allopurinol, oxypurinol, 
and lodoxamide is based on their action as xan- 
thine oxidase inhibitors and is presumed to pri- 
marily affect endothelial cells. These inhibitors 
block the conversion of hypoxanthine and xan- 
thine to uric acid and the generation of superox- 
ide anion and hydrogen peroxide (Fig 2). Recent 
studies indicate, however, that allopurinol and 
oxypurinol may also function as scavengers of the 
hydroxyl radical (“OH) and hypochlorous acid 
(HOCl). Therefore, the interpretation of experi- 
mental studies with these agents in the absence 
of direct measurements of purine metabolite 
formation must be carefully considered. 
Evidence suggests that lung injury expands 
during reperfusion after the initial ischemic 
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Fig 2. Mechanism by which xanthine oxidase 
inhibitors prevent superoxide anion production. 
insult. Attenuation of the injury by xanthine 
oxidase inhibitors such as allopurinol is depen- 
dent upon treatment of the tissue prior to isch- 
emia. If administration of the xanthine oxidase 
inhibitor is delayed until reperfusion, a marked 
decrease in the beneficial effect of the drug is 
observed. This requirement for pretreatment 
may reflect the need for the drug to be taken up 
by endothelial cells, or, regarding allopurinol, to 
be metabolized to a more active metabolite (oxy- 
purinol). 
Treatment 0fZntraoperative Right 
Ventricular Znjury§ 
One of the major risks of a repeat ster- 
notomy is massive bleeding secondary to right 
ventricular damage. In this case, as in most cases 
in which there is damage to the heart, the 
damage did not occur at the time of sternotomy. 
Rather, the damage occurred during retraction 
of the sternum. The appropriate treatment of this 
entity is the immediate institution of femoral- 
femoral bypass. In this instance, the heart was 
adherent to the undersurface of the chest wall. 
The chest wall was retracted up rather vigorously 
from the left side and a portion of the anterior 
wall of the right ventricle was retracted with the 
chest wall, causing severe hemorrhage. The 
wound was packed and femoral-femoral bypass 
was instituted immediately. The patient did not 
become hypotensive at the time and maintained 
systolic pressures of greater than 100 mmHg. 
Femoral-femoral bypass was instituted at nor- 
mothermia allowing dissection to gain access to 
the anterior right ventricular wall to facilitate 
repair of the damage. The real danger in this 
situation lies in attempts to immediately dissect 
the anterior right ventricular wall off the under- 
§G. Michael Deeb, MD 
surface of the sternum in an attempt to repair the 
damage. This would increase the size of the 
defect and the amount of bleeding; the patient 
would probably die. Partial bypass can be insti- 
tuted by using arterial access via the femoral 
artery and partial venous drainage via the femo- 
ral vein. Total bypass cannot be sustained 
because adequate venous drainage cannot be 
achieved using one cannula through the femoral 
vein. However, the venous return for bypass can 
be increased by placing the pump suckers 
through the hole in the anterior wall of the right 
ventricle. This maneuver will give the necessary 
venous return. Once bypass is begun, the. right 
ventricle will collapse, facilitating its dissection 
from the undersurface of the chest wall. Once the 
ventricle is freed from the chest wall the defect in 
the right ventricle can be repaired. When right 
ventricular repair was completed in this case, 
attempts were made to wean the patient from 
CPB. However, each time the heart was 
retracted for dissection of the coronary arteries, 
the patient’s pressure dropped precipitously. 
Because significant adhesions from previous sur- 
gery necessitated the retraction of the heart, the 
patient was maintained on partial bypass. 
The dissection was long (approximately 
three hours) and the patient was maintained on 
CPB at normothermia. The expected conse- 
quences of CPB at normothermia are a drop in 
systemic vascular resistance with vasodilation 
and the development of edema. The patient could 
not be cooled until access was gained to the left 
ventricle for decompression. Revascularization 
was performed without difficulty. During the 
process of weaning from cardiopulmonary 
bypass, there was good myocardial function. 
However, the patient could not be adequately 
oxygenated. Endotracheal suctioning produced 
pink, frothy material, and the chest x-ray showed 
bilateral interstitial pulmonary edema. 
There are three theoretical reasons for this 
patient’s pulmonary compromise. The first is 
CPB itself. There is much written in the litera- 
ture today about activation of complement C3A 
and C5A which causes sequestration of white 
cells, release of histamine, and formation of 
pulmonary edema. Complement activation oc- 
curs by the alternate pathway as a result of blood 
contact with materials such as silicone. An inter- 
esting study was performed comparing CPB with 
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membrane oxygenators and bubble oxygenators 
with and without steroids.16 There was evidence 
of significant sequestration of white blood cells 
and a marked increase in C3A with bubble 
oxygenators. There was no sequestration of white 
cells or activation of C3A with the membrane 
oxygenator, which was the type used in the case 
under discussion. With this method of oxygena- 
tion, the addition of steroids at the time of CPB 
decreased white cell sequestration. Steroids were 
not given in this case, and this may have allowed 
massive white cell sequestration. The second 
reason for a pulmonary capillary leak in this 
patient could have been multiple blood transfu- 
sions. Multiple blood transfusions can cause acti- 
vation of complement and sequestration of white 
cells with the build-up of granulocytes in the 
lungs, release of histamine, and superoxide for- 
mation. A third reason for the formation of 
pulmonary edema in this case could have been 
the complement activation seen in trauma 
patients with shock. However, this patient was 
never hypotensive. The reason for this patient’s 
pulmonary damage was probably twofold. It is 
unlikely that CPB elicits the activation of 
complement and sequestration of white cells; 
rather, massive transfusion was the culprit in this 
instance. Synergistic with this complement acti- 
vation was the long period of time during which 
CASE 2- 1988 
the patient had to be supported on partial bypass 
at normothermia, causing a drop in systemic 
vascular resistance, vasodilation, and a marked 
increase in blood flow to the lungs leading to 
complement activation and pulmonary edema. 
This patient not only had pulmonary ede- 
ma, but he also had total body edema. The 
myocardium functioned adequately, and the pul- 
monary artery and filling pressures were not 
high. The volume given to him went almost 
immediately into his soft tissues. His hematocrit 
rose above 30% in the early postoperative period 
and was kept above 30% thereafter. In the ICU, 
the problem was decreasing oxygenation, with 
subsequent deterioration of cardiac output and 
progressive acidosis. Because of hemodynamic 
instability, hemofiltration was not performed in 
this patient. The initial plan was to correct his 
coagulation factors and place him on ECMO 
eight to 10 hours postoperatively. The patient’s 
family, however, did not want to proceed with 
this therapeutic modality. Diuresis did not seem 
to be indicated despite the patient’s pulmonary 
edema. His filling pressures were not high and he 
was edematous. He was being given volume to try 
and maintain filling pressures and to increase his 
cardiac output. All fluid given, however, leaked 
into his soft tissue. It is appropriate to recognize 
that he had a total body capillary leak. 
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